NBP NovaBridge Biosciences

• $577K bought by 1 insider
• $32K sold by 2 insiders outside a trading plan
• None no planned (10b5-1) sales

1. Insider
   Trade
   Value
   Traded, filed
2. Phillip Andrew Dennis Chief Medical Officer
   Sale
   $5,828 8,209 shares at $0.7100 4.5% of stake
   Traded Sep 18 Filed Sep 21
   ↗
3. Cong Claire Xu EVP, Clinical Development
   Sale
   $2,593 3,282 shares at $0.7900 1.1% of stake
   Traded Aug 31 Filed Sep 1
   ↗
4. Cong Claire Xu SVP, Clinical Development
   Sale
   $3,992 4,485 shares at $0.8900 1.5% of stake
   Traded Jul 6 Filed Jul 7
   ↗
5. Phillip Andrew Dennis Chief Medical Officer
   Sale
   $5,606 8,494 shares at $0.6600 5.1% of stake
   Traded Jun 18 Filed Jun 22
   ↗
6. Cong Claire Xu SVP, Clinical Development
   Sale
   $14K 3,494 shares at $3.94 1.2% of stake
   Traded Jun 1 Filed Jun 2
   ↗
7. Mark Arnold Hagler See Remarks
   Buy
   $577K 230,000 shares at $2.51 New stake
   Traded Apr 24 Filed Apr 28
   ↗

Also filed in the last 12 months, not counted as buying or selling: 9 option exercises and 2 sales to cover taxes.